Cargando…
Chemical degradation of BTK/TEC as a novel approach to inhibit platelet function
[Figure: see text]
Autores principales: | Trory, Justin S., Munkacsi, Attila, Śledź, Kamila M., Vautrinot, Jordan, Goudswaard, Lucy J., Jackson, Molly L., Heesom, Kate J., Moore, Samantha F., Poole, Alastair W., Nabet, Behnam, Aggarwal, Varinder K., Hers, Ingeborg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182296/ https://www.ncbi.nlm.nih.gov/pubmed/36342848 http://dx.doi.org/10.1182/bloodadvances.2022008466 |
Ejemplares similares
-
Sphingosine-1-phosphate modulates PAR1-mediated human platelet activation in a concentration-dependent biphasic manner
por: Liu, Haonan, et al.
Publicado: (2021) -
Alterations in platelet proteome signature and impaired platelet integrin α(IIb)β(3) activation in patients with COVID-19
por: Goudswaard, Lucy J., et al.
Publicado: (2023) -
Severe B Cell Deficiency in Mice Lacking the Tec Kinase Family Members Tec and Btk
por: Ellmeier, Wilfried, et al.
Publicado: (2000) -
Effects of the Btk-Inhibitors Remibrutinib (LOU064) and Rilzabrutinib (PRN1008) With Varying Btk Selectivity Over Tec on Platelet Aggregation and in vitro Bleeding Time
por: Duan, Rundan, et al.
Publicado: (2021) -
Platelet procoagulant membrane dynamics: a key distinction between thrombosis and hemostasis?
por: Agbani, Ejaife O., et al.
Publicado: (2022)